- Home
- ARVN vs JQC Comparison
ARVN vs JQC Comparison
Compare ARVN & JQC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- JQC
- Stock Information
- Founded
- ARVN 2015
- JQC 2003
- Country
- ARVN United States
- JQC United States
- Employees
- ARVN N/A
- JQC N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- JQC Finance Companies
- Sector
- ARVN Health Care
- JQC Finance
- Exchange
- ARVN Nasdaq
- JQC Nasdaq
- Market Cap
- ARVN 676.2M
- JQC 753.9M
- IPO Year
- ARVN 2018
- JQC N/A
- Fundamental
- Price
- ARVN $10.59
- JQC $5.04
- Analyst Decision
- ARVN Buy
- JQC
- Analyst Count
- ARVN 23
- JQC 0
- Target Price
- ARVN $17.80
- JQC N/A
- AVG Volume (30 Days)
- ARVN 2.3M
- JQC 714.6K
- Earning Date
- ARVN 11-05-2025
- JQC 01-01-0001
- Dividend Yield
- ARVN N/A
- JQC 11.13%
- EPS Growth
- ARVN N/A
- JQC N/A
- EPS
- ARVN N/A
- JQC N/A
- Revenue
- ARVN $312,300,000.00
- JQC N/A
- Revenue This Year
- ARVN N/A
- JQC N/A
- Revenue Next Year
- ARVN N/A
- JQC N/A
- P/E Ratio
- ARVN N/A
- JQC N/A
- Revenue Growth
- ARVN 93.86
- JQC N/A
- 52 Week Low
- ARVN $5.90
- JQC $4.82
- 52 Week High
- ARVN $27.00
- JQC $5.65
- Technical
- Relative Strength Index (RSI)
- ARVN 59.44
- JQC 38.21
- Support Level
- ARVN $9.27
- JQC $5.08
- Resistance Level
- ARVN $11.51
- JQC $5.13
- Average True Range (ATR)
- ARVN 0.53
- JQC 0.05
- MACD
- ARVN 0.02
- JQC 0.01
- Stochastic Oscillator
- ARVN 59.15
- JQC 11.54
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About JQC Nuveen Credit Strategies Income Fund Shares of Beneficial Interest
Nuveen Credit Strategies Income Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. The fund meets its investment objectives by investing its managed assets in senior secured and second lien loans, and its managed assets across the capital structure of companies (including equity securities) with a primary emphasis on high yield bonds, convertible securities and other forms of income-producing securities.